Agilon Health, Inc.
General ticker "AGL" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $984.2M (TTM average)
Agilon Health, Inc. does not follow the US Stock Market performance with the rate: -40.3%.
Estimated limits based on current volatility of 6.7%: low 26.45$, high 30.28$
Factors to consider:
- Total employees count: 1076 (-3.7%) as of 2024
- Top business risk factors: History of net losses and increasing expenses, Failure to develop new geographies and payors, Operational and conduct risks, Inability to secure MA payor contracts, Significant reduction in membership
- Earnings for 12 months up through Q4 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [21.65$, 75.94$]
- 2025-12-31 to 2026-12-31 estimated range: [17.83$, 59.08$]
Financial Metrics affecting the AGL estimates:
- Negative: with PPE of -79.8 at the end of fiscal year the price was very high
- Negative: Operating cash flow per share per price, % of -7.34 <= 0.07
- Positive: -4.72 < Operating profit margin, % of -4.60
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of 3.28 <= 5.46
- Positive: 19.49 < Shareholder equity ratio, % of 27.16 <= 42.60
- Negative: 0.73 < Interest expense per share per price, % of 0.78
Short-term AGL quotes
Long-term AGL plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,388.22MM | $4,316.36MM | $6,060.53MM |
| Operating Expenses | $2,493.60MM | $4,548.50MM | $6,352.66MM |
| Operating Income | $-105.38MM | $-232.13MM | $-292.13MM |
| Non-Operating Income | $14.71MM | $37.67MM | $43.30MM |
| Interest Expense | $4.48MM | $6.66MM | $6.18MM |
| Income(Loss) | $-90.67MM | $-194.46MM | $-248.83MM |
| Taxes | $1.64MM | $0.79MM | $1.45MM |
| Other Income(Loss) | $0.47MM | $-67.55MM | $-9.82MM |
| Profit(Loss)* | $-106.55MM | $-262.60MM | $-260.15MM |
| Stockholders Equity | $1,041.22MM | $661.84MM | $470.95MM |
| Assets | $1,697.47MM | $1,740.87MM | $1,733.98MM |
| Operating Cash Flow | $-130.81MM | $-156.20MM | $-57.78MM |
| Capital expenditure | $32.66MM | $30.82MM | $13.25MM |
| Investing Cash Flow | $-444.39MM | $-44.02MM | $139.89MM |
| Financing Cash Flow | $28.06MM | $-193.13MM | $-2.58MM |
| Earnings Per Share** | $-6.53 | $-16.05 | $-15.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.